Oruka Therapeutics, Inc.·4

Sep 19, 5:33 PM ET

Fairmount Healthcare Fund II L.P. 4

4 · Oruka Therapeutics, Inc. · Filed Sep 19, 2025

Insider Transaction Report

Form 4
Period: 2025-09-17
Transactions
  • Award

    Common Stock

    2025-09-17$15.00/sh+333,340$5,000,1001,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
  • Common Stock

    (indirect: By Fairmount Healthcare Co-Invest III L.P.)
    2,573,308
Footnotes (2)
  • [F1]The shares of Common Stock were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended.
  • [F2]Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest III L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Documents

1 file
  • 4
    tm2526585-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT